Filing Details
- Accession Number:
- 0001209191-12-054996
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-29 18:03:55
- Reporting Period:
- 2012-11-27
- Filing Date:
- 2012-11-29
- Accepted Time:
- 2012-11-29 18:03:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427971 | Cathy Fraser | 1445 Ross Avenue Suite 1400 Dallas TX 75202 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-11-27 | 11,760 | $27.82 | 14,575 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-27 | 2,500 | $27.86 | 12,075 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-11-27 | 100,000 | $4.56 | 112,075 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-27 | 46,848 | $27.87 | 65,227 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2009 Options (Right to Buy) | Disposition | 2012-11-27 | 100,000 | $0.00 | 100,000 | $4.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-02-26 | No | 4 | M | Direct |
Footnotes
- All historical share and stock option exercise price data in this Form 4 have been restated to reflect a one-for-four reverse stock split effective as of October 11, 2012.
- The shares were sold in open market broker transactions. The reporting person continues to exceed the Company's stock ownership guidelines.
- The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $27.78 to $27.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Represents number of shares withheld by the Company at the direction of the reporting person for the payment of option exercise price and related taxes. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (53,152 shares).
- As previously reported, the options were granted on February 26, 2009 and vested ratably on each of the first, second and third anniversaries of the date of grant.